CU Anschutz Cancer Center

CU Cancer Center-led research shows how breast cancer cells hijack the lung's natural repair system, fueling tumor growth in patients who develop lung metastases. However, a repurposed drug may slow it down: https://bit.ly/3NGY01H

Overseen by cardiologist Lavanya Kondapalli, MD, the University of Colorado Cardio-Oncology Program helps people with heart conditions undergoing treatment, as well as those who develop heart-related side effects from cancer therapies: https://bit.ly/4yu92Zc

Today's 3rd Annual Lobular Breast Cancer Awareness Day in Colorado event brought together patients, educators, researchers, and advocacy partners from across the Front Range. 🩷 Learn all about the second most common type of breast cancer here: https://bit.ly/4B9nPer

What can Pope Leo XIV’s surgery tell us about lung cancer diagnosis and treatment? CU Anschutz Cancer Center member Elizabeth A. David, MD, MAS, answers this question and more: https://news.cuanschutz.edu/cancer-center/pope-leo-xiv-lung-cancer

"Sometimes we get the idea that breast cancer is a disease of young people, and there's a lot of information about that. But the truth is that the face of breast cancer is the face of an older adult,” says CU Anschutz Cancer Center leaer Enrique Soto Pérez de Celis, MD, PhD: https://bit.ly/4dGzEPf

Overseen by CU Anschutz Cancer Center's Bennett Chin, MD, a new theranostics suite at UCHealth University of Colorado Hospital will streamline treatment and clinical trials for certain types of cancer, notably prostate cancer and neuroendocrine tumors: https://bit.ly/3TNjX25

CU Anschutz Cancer Center member Alessandra Brambati, PhD, has received a National Institutes of Health Director’s New Innovator Award to build the molecular tools needed to study RNA-templated repair: https://news.cuanschutz.edu/medicine/nih-directors-innovator-award-2026

“Dr. Lieu always has my family’s best interests in mind, and we have a great deal of trust in him," says Ross Matthews. Read about Matthews' six-year journey with stage 4 colorectal cancer and why he has participated in clinical research here at @cuanschutz.bsky.social: https://bit.ly/4iZC8vE

The CU Anschutz Cancer Center is the only location in the Rocky Mountains actively recruiting for the EvoPAR-Breast01 worldwide clinical trial. Cancer center's Marie Wood, MD, is the @cuanschutz.bsky.social site principal investigator, learn more: https://bit.ly/4nTAEU6

CU Anschutz Cancer Center member Allison L’Hotta, OTD, OTR/L, PhD, received funding from the National Cancer Institute to pilot an electronic health record integration strategy for symptom screening and management in children undergoing cancer treatment: https://bit.ly/4dck6m9

For Prostate Cancer Awareness Month, CU Anschutz Cancer Center's David Strauss, MD, and Jan Lowery, PhD, MPH, talk how screening has changed for the disease over the years and what the future may look like: https://news.cuanschutz.edu/cancer-center/lowery-strauss-prostate-cancer-screening

New ideas often emerge through conversation. Jill Slansky, PhD, highlights how the Tumor Immunology Forum brings researchers together to discuss emerging approaches, share expertise, and spark innovative thinking in tumor immunology and cancer research. Full interview: youtu.be/d_CDwlhDNig?...

CU Anschutz Cancer Center's Rebecca Schweppe, PhD, Bryan Haugen, MD, and Jennifer Richer, PhD, received a $1.75 million grant from the DOD to translate their research into a new treatment for thyroid cancers that resist standard medications: https://bit.ly/4hJfHcS

The family of Ian Shelton, PhD, which has deep CU ties, is providing major philanthropic support for an acute myeloid leukemia (AML) clinical trial run by CU Anschutz Cancer Center member Andrew Kent, MD, PhD: https://news.cuanschutz.edu/cancer-center/kent-shelton-aml-trial

CU Anschutz Cancer Center's Theresa Medina, MD, provides insight into what impact the Keytruda-intismeran combination may have for high-risk melanoma patients ⬇️ https://www.uchealth.org/today/mrna-cancer-vaccine-with-keytruda-sharply-improves-melanoma-survival/

Congratulations to Wells Messersmith, MD, the new director of the CU Anschutz Cancer Center. See the full statement: https://bit.ly/4yiL1oE

The @theaacr.bsky.social's 2026 Cancer Progress Report highlights the latest progress in the fight against cancer. CU Anschutz Cancer Center leader James DeGregori, PhD, shares his thoughts as a member of the report's steering committee: https://bit.ly/46C4TXR

CU Anschutz Cancer Center's Laura Graham, MD, and Enrique Soto, MD, PhD, share their thoughts on hormone therapy as a treatment for breast cancer and prostate cancer ⬇️ https://news.cuanschutz.edu/cancer-center/hormone-therapy-breast-prostate-cancer

📸 from Cancer League Colorado's Over the Edge this morning! James DeGregori, PhD, interim director, and Mercedes Rincon, PhD, a cancer center member, rappelled down the Kimpton Claret Hotel for Colorado-based cancer research. 💛

CU Anschutz Cancer Center's Maria Amaya (@mariaamaya27.bsky.social), MD, PhD, shares why last Friday's Mentored Member Collaborative Forum is important for mentored members like herself.

The CU Anschutz Cancer Center is hosting the second annual Rising Star Over the Rockies Conference! With this event, researchers discuss innovative research, early detection, multidisciplinary care, and education.

.@cuanschutz.bsky.social researchers have identified a biological pathway that may contribute to muscle and bone loss in colorectal cancer, providing new insight into the mechanisms behind cancer-related wasting and a potential target for future study: https://bit.ly/4zWVIPj

Towards the end of August, the Rady Esophageal and Gastric Center of Excellence hosted its second annual Research Day along with a two-day immersive grant-writing workshop! Thank you to everyone who came out for these events and made them possible.

Through the CU-GENES study, Colorado adults of Jewish ancestry can receive free at-home genetic testing. For Michele Frishman, this program helped her learn she was positive for a BRCA1 mutation, a mutation that increases breast and ovarian cancer risk: https://bit.ly/4gzoaiu

A novel combination therapy with first-in-human roots at @cuanschutz.bsky.social delivered effective and durable responses in patients with advanced, muscle-invasive bladder cancer, according to a new study in the New England Journal of Medicine (@nejm.org): https://bit.ly/4gy26on

In a new study, Ajay Major (@majorajay.bsky.social), MD, MBA, and Vincenzo Pizzuti, MD, MS, have tracked a group of blood cancer patients using multiple surveys over the course of two years to see how CAR T-cell therapy impacts their health-related quality of life: https://bit.ly/3UzIYxF

Prostate Cancer Awareness Month: Two CU Anschutz Cancer Center clinical trials may offer new hope for patients with advanced prostate cancer, where the disease has spread beyond the prostate gland and is no longer responding to hormone therapies: https://bit.ly/4gOUr3Z

CU Anschutz Cancer Center member and pediatric oncologist Vanessa Ann Fabrizio, MD, MS, breaks down how leukemia in children is different from adult cases. Learn more: https://medschool.cuanschutz.edu/colorado-cancer-center/for-patients-families/cancers-we-treat/leukemia

On 9NEWS, CU Anschutz Cancer Center leader and principal investigator for the treatment, Wells Messersmith, MD, shares his thoughts on the FDA approving daraxonrasib and how it works against pancreatic cancer: https://bit.ly/46EfNfv

CU Anschutz Cancer Center researchers are making progress on finding better treatments for mucosal melanomas. A recent phase I clinical trial showed early promise for overcoming immunotherapy resistance in rare melanomas. Learn more: https://bit.ly/4wMpSSh

The U.S. Food and Drug Administration approved a new treatment option for patients with advanced pancreatic cancer. Read more about the breakthrough drug from Chris Lieu, MD, associate director of clinical research: https://bit.ly/4efMpkJ

Immunotherapy, over the last couple of years, promises results for cancer patients for whom other types of treatment have proven ineffective. CU Anschutz Cancer Center leaders explain how it works ⬇️ https://news.cuanschutz.edu/cancer-center/what-is-immunotherapy

Immunotherapy, over the last couple of years, promises results for cancer patients for whom other types of treatment have proven ineffective. CU Anschutz Cancer Center leaders explain how it works ⬇️ https://news.cuanschutz.edu/cancer-center/what-is-immunotherapy

Tomorrow is National Surgical Oncologist Day! CU Anschutz Cancer Center member and @cudeptsurg.bsky.social surgical oncologist Martin McCarter, MD, shares how surgical oncologists face and treat a variety of cancer cases. Learn more: https://news.cuanschutz.edu/cancer-center/cancer-surgery

At age 35, a mutated CHEK2 gene led to breast cancer, thyroid cancer, and a colon cancer scare. Read about Karissa Goossen's perseverance and what she has learned through her journey: https://www.uchealth.org/today/chek2-gene-mutation-breast-thyroid-colon-cancer-risk/

In this AJMC interview, CU Anschutz Cancer Center's Urs Weber, MD, talks about a multidisciplinary care approach to comprehensive biomarker testing and target therapies for lung cancer patients: https://bit.ly/4cH1vOH

Eileen Walker has been living life to the fullest after being diagnosed with stage 4 appendix cancer in 2019. Through the ups and downs, she’s grateful to Steven Ahrendt, MD, the CU Anschutz Cancer Center surgeon who removed her appendix cancer. Read more of Walker's story: https://bit.ly/4zoJrTm

Backed by an NCI grant and working in the lab of CU Anschutz Cancer Center leader Eduardo Davila, PhD, Gabriella Albert is looking to see why certain modified T cells don’t stop fighting cancer in the same way as non-modified T cells: https://bit.ly/3S1qkOr

CU Anschutz Cancer Center researchers have identified a previously unknown metabolic weakness in the stem cells that drive high-risk myelodysplastic syndromes, a discovery that could lead to more targeted treatments for this aggressive blood cancer: https://bit.ly/4gboR04

CU Anschutz Cancer Center leader Patricia Ernst, PhD, will research new treatments for infant acute lymphoblastic leukemia (ALL), with funding from a $1 million grant from the V Foundation for Cancer Research: https://news.cuanschutz.edu/cancer-center/million-dollar-grant-pediatric-all

What causes ER-positive breast cancer to spread to the brain? New research from CU Anschutz Cancer Center's Diana Cittelly, PhD, may have found the reason why: https://news.cuanschutz.edu/cancer-center/what-causes-er-positive-breast-cancer-to-spread-to-the-brain

CU Anschutz Cancer Center's Peter E. Fecci, MD, PhD, spoke with @onclive.bsky.social about recent therapeutic advances and ongoing challenges in the management of glioblastoma ⬇️ https://www.onclive.com/view/dr-fecci-on-immunotherapy-research-innovations-in-glioblastoma

With this new CU Anschutz Cancer Center summer program called START, middle- and high-school students are learning about cancer research, rubbing elbows with experts, tackling cancer-biology problems in exercises, and getting hands-on experience in labs: https://bit.ly/4q7WPab

The CU Anschutz Cancer Center's Cancer Research Experience for Undergraduates (CREU) and Summer Undergraduate Research Fellowship (SURF) have completed their 2026 cohort! Learn more about these fun hands-on programs: https://bit.ly/4fyG8zm

Congrats to all 43 of our members who made the 2026 5280 Magazine Top Doctors list! 🏆 ⭐ See the full list of @cumedicalschool.bsky.social Top Doctors here: https://news.cuanschutz.edu/medicine/5280-magazine-top-doctors-for-2026

After an esophageal cancer diagnosis, Don McCoy avoided surgery and chemotherapy thanks to innovative treatment from cancer center member Sunnie Kim, MD. Read his story: https://bit.ly/3TropmA

CU Anschutz Cancer Center's Laura Graham, MD, saw an increase from 30% to 72% of eligible patients getting tested for prostate cancer under a new approach ⬇️ https://news.cuanschutz.edu/cancer-center/onsite-genetic-testing-prostate-cancer

#WorldHeadAndNeckCancerDay: CU Anschutz Cancer Center's Carissa Thomas, MD, PhD, FACS, shares the truth about these head and neck cancer myths: https://bit.ly/4fjkwsp

At the 2026 American Urological Association Annual Meeting, CU Anschutz Cancer Center's Janet Kukreja, MD, MPH, spoke with Leslie Ballas, MD, and Ashish Kamat, MD, MBBS, about bladder cancer radiation toxicity management: https://bit.ly/3Twa3Bh

2026 Courage Classic: Interim Director James DeGregori, PhD, was among the nearly 400 participants, which included fellow @cuanschutz.bsky.social faculty, family, friends, caregivers, and cancer survivors who made up the Wheels of Justice team.